CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

SEGALL BRYANT & HAMILL, LLC's Holding History (CIK: 0001006378)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 189,477 Value ($000) $8,820 Avg Close $44.52 Range $38.81 - $50.98

Q3 2025

Shares 180,849 Value ($000) $7,532 Avg Close $31.97 Range $25.83 - $47.41

Q2 2025

Shares 176,517 Value ($000) $5,077 Avg Close $30.88 Range $24.10 - $34.68

Q1 2025

Shares 146,274 Value ($000) $4,906 Avg Close $37.35 Range $31.65 - $53.55

Q4 2024

Shares 150,398 Value ($000) $7,690 Avg Close $55.95 Range $49.48 - $62.53

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	189,477	$8,820	$44.52	$38.81 - $50.98
Q3 2025	180,849	$7,532	$31.97	$25.83 - $47.41
Q2 2025	176,517	$5,077	$30.88	$24.10 - $34.68
Q1 2025	146,274	$4,906	$37.35	$31.65 - $53.55
Q4 2024	150,398	$7,690	$55.95	$49.48 - $62.53